Hypoxia imaging with the nitroimidazole 18F-FAZA PET tracer: a comparison with OxyLite, EPR oximetry and 19F-MRI relaxometry

Radiother Oncol. 2012 Oct;105(1):29-35. doi: 10.1016/j.radonc.2012.04.011. Epub 2012 Jun 6.

Abstract

Background and purpose: (18)F-FAZA is a nitroimidazole PET tracer that can provide images of tumor hypoxia. However, it cannot provide absolute pO(2) values. To qualify (18)F-FAZA PET, we compared PET images to pO(2) measured by OxyLite, EPR oximetry and (19)F-MRI.

Materials and methods: Male WAG/Rij rats grafted with rhabdomyosarcoma were used. Tumor oxygenation was modified by gas breathing (air or carbogen). The same day of PET acquisition, the pO(2) was measured in the same tumor either by OxyLite probes (measurement at 10 different sites), EPR oximetry using low frequency EPR or (19)F-relaxometry using 15C5 on an 11.7T MR system.

Results: There was a good correlation between the results obtained by PET and EPR (R = 0.93). In the case of OxyLite, although a weaker correlation was observed (R = 0.55), the trend for two values to agree was still related to the inverse function theoretically predicted. For the comparison of (18)F-FAZA PET and (19)F-MRI, no change in T(1) was observed.

Conclusions: A clear correlation between (18)F-FAZA PET image intensities and tumor oxygenation was demonstrated, suggesting that (18)F-FAZA PET is a promising imaging technique to guide cancer therapy.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Hypoxia
  • Fluorine Radioisotopes
  • Magnetic Resonance Imaging / methods*
  • Male
  • Neoplasms, Experimental / diagnostic imaging
  • Nitroimidazoles*
  • Oximetry / methods*
  • Positron-Emission Tomography / methods*
  • Radiopharmaceuticals
  • Rats
  • Rhabdomyosarcoma / diagnostic imaging

Substances

  • Fluorine Radioisotopes
  • Nitroimidazoles
  • Radiopharmaceuticals